Top Markets
Coin of the day
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Rank in Stocks #6695
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jรถrgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgรฅrd Schambye, its corporate operations are based in Boston, Massachusetts.
Share Price
$30.90
Market Cap
$1.90B
Change (1 day)
1.68%
Change (1 year)
819.64%
Country
US
Trade Damora Therapeutics, Inc. (DMRA)

Category

Stock split history for Damora Therapeutics, Inc. (DMRA)
Damora Therapeutics, Inc. stock (symbol: DMRA) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 27, 2026.
One DMRA share bought prior to Aug 27, 2026 would equal to 0 DMRA shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH